INM
NASDAQ · Pharmaceuticals
Inmed Pharmaceuticals Inc
$1.55
+0.05 (+3.33%)
Open$1.51
Previous Close$1.50
Day High$1.58
Day Low$1.50
52W High$5.50
52W Low$0.58
Volume—
Avg Volume64.3K
Market Cap4.94M
P/E Ratio—
EPS$-2.88
SectorPharmaceuticals
Analyst Ratings
Strong Sell
8 analysts
Price Target
+2,071.0% upside
Current
$1.55
$1.55
Target
$33.65
$33.65
$24.21
$33.65 avg
$46.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 16.78M | 10.14M | 790.8K |
| Net Income | -27,714,846 | -15,066,965 | 172.0K |
| Profit Margin | -165.1% | -156.9% | 21.8% |
| EBITDA | -26,260,304 | -15,069,337 | 218.3K |
| Free Cash Flow | — | — | 109.5K |
| Rev Growth | +65.6% | +65.6% | +11.4% |
| Debt/Equity | — | — | 0.10 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |